Target type: molecularfunction
Catalysis of the reaction: cholesterol + NADP+ = 7-dehydrocholesterol + H+ + NADPH. [RHEA:23984]
7-dehydrocholesterol reductase activity, also known as DHCR7 activity, is a crucial enzymatic step in the biosynthesis of cholesterol. This enzyme catalyzes the reduction of 7-dehydrocholesterol (7-DHC), a precursor to cholesterol, to cholesterol. The reaction involves the transfer of a hydride ion from NADPH to the double bond at carbon 7 of 7-DHC. This specific enzymatic activity is essential for the production of cholesterol, a vital molecule involved in various cellular processes, including membrane fluidity, hormone synthesis, and vitamin D production. Deficiency in DHCR7 activity leads to Smith-Lemli-Opitz syndrome (SLOS), a rare genetic disorder characterized by severe neurological impairments, developmental delays, and physical abnormalities.'
"
Protein | Definition | Taxonomy |
---|---|---|
7-dehydrocholesterol reductase | A 7-dehydrocholesterol reductase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UBM7] | Homo sapiens (human) |
7-dehydrocholesterol reductase | A 7-dehydrocholesterol reductase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UBM7] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
chrysamine g | chrysamine G: structure given in first source; RN refers to disodium salt | ||
tamoxifen | stilbenoid; tertiary amino compound | angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator |